Ralph Jordan Email & Phone Number

Ingelheim Am Rhein, Rhineland-Palatinate, DE

Global Business Development and Licensing

New York, NY, US

• Advise healthcare / life science companies on business development initiatives and commercial transactions.
• Executed multiple biotech licenses critical for development of client’s leading pipeline compounds
• Negotiated $1M+ commercial manufacturing deal with oversees CDMO for flagship product
• Facilitated opportunity to monetize $10M+ royalty stream from big pharma

Alpharetta, Georgia, US

• Structured, negotiated and implemented business development and commercial initiatives including acquiring technology and products, go to market programs, international distributorships, divestitures and commercial.
• Led $300M restructuring of supply arrangement with Kimberly Clark which was cornerstone to Avanos divesting business line having $1B of revenue
• Optimized return on $65M tuck-in acquisition by revamping its distribution network
• Following $710M product line divestiture, led negotiations with European partners for migration of contracts integral to the transaction
• Capitalized on business opportunities through creatively structured channel partnerships

Marietta, Georgia, US

• Co-founded next generation, orthopedic, digital surgical systems company (Polaris) using proprietary, leading edge, wireless sensor technology and analytics
• Built / led team of employees; full P&L responsibility; developed business model
• Converted networking to C-level meetings and term sheet for acquisition of Polaris for $40M
• Polaris merged with company having complementary orthopedic technology in 2015 forming MiRus

Atlanta, GA, US

• Grew market “footprint” and valuation of CardioMEMS, resulting in $450M exit through acquisition by St. Jude Medical. Completed transactions among the leading global medical technology and pharmaceutical companies for.
• Created second market for CardioMEMS through partnerships with big pharma
• Executed $10M+ out-licensing / development deal with world’s largest orthopedic trauma company
• Led negotiations and closed transactions with 50+ leading hospitals across U.S.
• Introduced St. Jude Medical corporate opportunity to Board of Directors; designed / implemented exit strategy in collaboration with Board; originated potential acquirers across diverse industries
• Served pivotal role in raising $50M by positioning CardioMEMS among investors in C, D and E rounds

Florham Park, New Jersey, US

• Grew Sciele (which was acquired by Shionogi) from private, $20M revenue, regional, cough/cold products company to a premier specialty pharmaceutical company with over $300M in revenue by “selling” Sciele’s product.
• Completed licensing, acquisitions, partnerships and other transactions (up to $200M+ each) with global partners including AstraZeneca, Bayer, Pfizer, Warner-Lambert, Wyeth, American Home Products, Elan, Sanofi.
• Presented to / secured Board of Director's approval for $250M acquisition providing entry into medical device market
• Facilitated $30M+ IPO as part of senior management team
• Sciele was acquired by Shionogi in 2008 for $1.4B

Structured ventures facilitating clients achieving business goals. Advised clients in matters related to Fortune 500 companies including acquisitions, licensing, commercial law and financings.

US

Represented companies in matters including joint ventures, acquisitions, contracts, copyright, trademark, secured financings, creditors’ rights, litigation and franchising.

B.S. Commerce, Finance

J.D.

M.B.A.